IL6 and obesity disorder: Obesity in this model was not associated with significant increases in circulating levels of 17β-estradiol or testosterone, or in circulating levels of inflammatory markers, including CRP, tissue plasminogen activator inhibitor 1, TNF-α, MCP, IL-6, or corticosterone (Table 1).